Evidence mapPaperPMID 12234233Full record

ReviewJAMA2002

New evidence for stroke prevention: scientific review.

Sharon E Straus, Sumit R Majumdar, Finlay A McAlister

Abstract readReview
PubMed Publisher
In one paragraph

Review in JAMA, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 3 pooled it
27.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 3 syntheses or guidelines pooled it, 297 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2014
    Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Modeling Survival in Patients With Brain Stroke in the Presence of Competing Risks.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sharon E StrausDivision of General Internal Medicine, Department of Medicine, University Health Network, Toronto General Hospital, 200 Elizabeth St, ENG 248, Toronto, Ontario, Canada M5G 2C4. sstraus@mtsinai.on.ca
Sumit R Majumdar
Finlay A McAlister
University Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextStroke is a major cause of morbidity and mortality, and the application of evidence for stroke prevention varies considerably.

objectiveTo review the most recent, high-quality evidence for primary and secondary stroke prevention. DATA SOURCES AND STUDY SELECTION: Searches of MEDLINE, The Cochrane Library, and the ACP Journal Club were performed to identify English-language articles published from 1998 to 2001 that focused on primary and secondary stroke prevention. The references of each retrieved article were scanned, and experts in the field were contacted to identify additional relevant articles. DATA EXTRACTION: Each of the articles was appraised, and its quality was graded with levels of evidence based on specific scientific methods that affect a study's validity. DATA SYNTHESIS: For primary prevention of stroke, adequate blood pressure reduction, and treatment of hyperlipidemia, use of antithrombotic therapy in patients with atrial fibrillation and of antiplatelet therapy in patients with myocardial infarction are effective and supported by evidence from several randomized trials. Effective strategies for the secondary prevention of stroke include treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, antiplatelet therapy, and carotid endarterectomy in patients with severe carotid artery stenosis.

conclusionsStroke is a major public health concern, and a significant body of evidence supports many primary and secondary prevention strategies.

Indexed as

AgedAged, 80 and overAngiotensin-Converting Enzyme InhibitorsAnticoagulantsAtrial FibrillationDiabetes MellitusEndarterectomy, CarotidFemaleFibrinolytic AgentsHumansHyperlipidemiasHypertensionMaleMiddle AgedMyocardial InfarctionPlatelet Aggregation InhibitorsAngiotensin-Converting Enzyme InhibitorsAnticoagulantsFibrinolytic AgentsPlatelet Aggregation Inhibitors

Identifiers

PMID12234233
OpenAlexW2056414983

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.